S
Spiderwort
Spiderwort is a novel biomaterial that will offer new avenues in regenerative medicine
About Spiderwort
Spiderwort is a biotechnology company specializing in cellulose-based biomaterials designed to serve as scaffolds for regenerative medicine, tissue engineering, and lab-grown meat. The company's core products include CelluBridge, a cellulose-based scaffold that promotes spinal cord repair and regeneration, and CelluJuve, a cellulose-based dermal filler for injury recovery and cosmetic enhancement. Spiderwort operates in the biotechnology and medical device markets, targeting healthcare providers, research institutions, and potentially the food industry. The business model revolves around the development, production, and sale of these innovative biomaterials. Revenue is generated through product sales, research partnerships, and potential licensing agreements. Spiderwort's proprietary plant-based scaffolding technology positions it as a transformative player in the field of regenerative medicine and beyond.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Ottawa, Canada
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 72.4/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Open Source, Biotechnology, Biomaterials, Spinout, Biotech and Pharma, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| OtherOther financing | Jun 2023 | $0 | — | Undisclosed | ↗ |
| SERIES A✓Equity / VC | Jul 2022 | $13M | $53M | BoxOne Ventures · Break Off Capital · Horizons Ventures · K5 Global | ↗ |
Growth signals
Latest recorded traffic for Spiderwort is 1.4K monthly website visits, down 22.2% over the last three months. Spiderwort's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Ontario Brain Institute
Horizons Ventures
Capital Angel Network
Anges Quebec
Break Off Capital
Series A3 investors entered at this stage
K5 Global- VSVentured Synergy
BoxOne Ventures
Other known investors6 additional known investors
University of Ottawa
Christer Andersson
Creative Destruction Lab
Flucas Ventures
Groupe Roski
Sommet
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Spiderwort on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Spiderwort’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.